AB Stable VIII LLC v. MAPS Hotels and Resorts One LLC

CourtCourt of Chancery of Delaware
DecidedNovember 30, 2020
DocketC.A. No. 2020-0310-JTL
StatusPublished

This text of AB Stable VIII LLC v. MAPS Hotels and Resorts One LLC (AB Stable VIII LLC v. MAPS Hotels and Resorts One LLC) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
AB Stable VIII LLC v. MAPS Hotels and Resorts One LLC, (Del. Ct. App. 2020).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

AB STABLE VIII LLC, ) ) Plaintiff/Counterclaim-Defendant, ) ) v. ) C.A. No. 2020-0310-JTL ) MAPS HOTELS AND RESORTS ONE LLC, MIRAE ) ASSET CAPITAL CO., LTD., MIRAE ASSET ) DAEWOO CO., LTD., MIRAE ASSET GLOBAL ) INVESTMENTS, CO., LTD., and MIRAE ASSET ) LIFE INSURANCE CO., LTD., ) ) Defendants/Counterclaim-Plaintiffs. )

MEMORANDUM OPINION

Date Submitted: October 28, 2020 Date Decided: November 30, 2020

Raymond J. DiCamillo, Kevin M. Gallagher, Sara A. Clark, John M. O’Toole, RICHARDS LAYTON & FINGER, P.A., Wilmington, Delaware; Adam H. Offenhartz, Marshall R. King, Shireen A. Barday, Nathan C. Strauss, GIBSON, DUNN & CRUTCHER LLP, New York, New York; Tyler A. Amass, GIBSON, DUNN & CRUTCHER LLP, Denver, Colorado; Attorneys for Plaintiff and Counterclaim Defendant AB Stable VIII LLC.

A. Thompson Bayliss, Michael A. Barlow, Stephen C. Childs, ABRAMS & BAYLISS LLP, Wilmington, Delaware; Michael B. Carlinsky, Andrew J. Rossman, Christopher D. Kercher, Rollo C. Baker IV, QUINN EMANUEL URQUHART & SULLIVAN, LLP, New York, New York; Kap-You Kim, PETER & KIM ATTORNEYS AT LAW, Seoul, South Korea; Attorneys for Defendants and Counterclaim Plaintiffs Maps Hotels and Resorts One LLC, Mirae Asset Capital Co., Ltd., Mirae Asset Daewoo Co., Ltd., Mirae Asset Global Investments, Co., Ltd., and Mirae Asset Life Insurance Co., Ltd.

LASTER, V.C. AB Stable VIII LLC (“Seller”) is an indirect subsidiary of Dajia Insurance Group,

Ltd. (“Dajia”), a corporation organized under the law of the People’s Republic of China.

Dajia is the successor to Anbang Insurance Group., Ltd. (“Anbang”), which was also a

corporation organized under the law of the People’s Republic of China. For simplicity, and

because Anbang was the pertinent entity for much of the relevant period, this decision

refers to both companies as “Anbang.”

Through Seller, Anbang owns all of the member interests in Strategic Hotels &

Resorts LLC (“Strategic,” “SHR,” or the “Company”), a Delaware limited liability

company. Strategic in turn owns all of the member interests in fifteen limited liability

companies, each of which owns a luxury hotel.

Under a Sale and Purchase Agreement dated September 10, 2019 (the “Sale

Agreement” or “SA”), Seller agreed to sell all of the member interests in Strategic to MAPS

Hotel and Resorts One LLC (“Buyer”) for a total purchase price of $5.8 billion (the

“Transaction”). Buyer is a special purpose vehicle formed to acquire Strategic. Buyer’s

ultimate parent company is Mirae Asset Financial Group (“Mirae”), a financial services

conglomerate based in Korea with assets under management of over $400 billion. Three of

Mirae’s affiliates executed equity commitment letters that bound them to contribute a total

of $2.2 billion to Buyer at closing. The balance of the purchase price would be funded with

debt. Due to a combination of factors, Buyer was not able to obtain debt financing.

On April 17, 2020, the scheduled closing date, Buyer asserted that a number of

Seller’s representations and warranties were inaccurate and that Seller had failed to comply

with its covenants under the Sale Agreement. Buyer contended that as a result, Seller had

1 failed to satisfy all of the conditions to closing, and Buyer was not obligated to close. Buyer

informed Seller that if the breaches were not cured on or before May 2, 2020, then Buyer

would be entitled to terminate the Sale Agreement.

On April 27, 2020, Seller filed this action seeking a decree of specific performance

(i) compelling Buyer to perform its obligations under the Sale Agreement and (ii) directing

Buyer’s three affiliates to contribute $2.2 billion under the equity commitment letters. After

Seller filed suit, Buyer purported to terminate the Sale Agreement. Buyer then filed

counterclaims seeking determinations that Seller failed to satisfy conditions to closing,

breached its express contractual obligations, breached implicit obligations supplied by the

implied covenant of good faith and fair dealing, and committed fraud.

The initial set of issues involves Buyer’s obligation to close. The factual

underpinnings of those issues fall into two largely distinct categories: the “COVID Issues”

and the “DRAA Issues.”

The COVID Issues are factually straightforward and result from the COVID-19

pandemic. First, Buyer was not obligated to close if Seller’s representations were

inaccurate and the degree of the inaccuracy was sufficient to result in a contractually

defined Material Adverse Effect (the “Bring Down Condition”). Seller represented that

since July 31, 2019, there had not been any changes, events, states of facts, or

developments, whether or not in the ordinary course of business that, individually or in the

aggregate, have had or would reasonably be expected to have a Material Adverse Effect.

(the “No-MAE Representation”).

2 According to Buyer, the business of Strategic and its subsidiaries suffered a Material

Adverse Effect due to the onset of the COVID-19 pandemic, rendering the No-MAE

Representation inaccurate, causing the Bring-Down Condition to fail, and relieving Buyer

of its obligation to close. Assuming for purposes of analysis that Strategic suffered an effect

that was both material and adverse, Seller nevertheless proved that the consequences of the

COVID-19 pandemic fell within an exception to the definition for effects resulting from

“natural disasters and calamities.” Consequently, the business of Strategic and its

subsidiaries did not suffer a Material Adverse Effect as defined in the Sale Agreement.

Second, Buyer was not obligated to close if Seller failed to comply with its

covenants between signing and closing (the “Covenant Compliance Condition”). Seller’s

covenants included a commitment that the business of Strategic and its subsidiaries would

be conducted only in the ordinary course of business, consistent with past practice in all

material respects (the “Ordinary Course Covenant”).

Buyer proved that due to the COVID-19 pandemic, Strategic made extensive

changes to its business. Because of those changes, its business was not conducted only in

the ordinary course of business, consistent with past practice in all material respects. The

Covenant Compliance Condition therefore failed, relieving Buyer of its obligation to close.

Unlike the COVID Issues, the DRAA Issues are factually complex. They relate to a

fraudulent scheme whose origins date back to 2008, when Anbang began a series of

3 disputes with a shadowy and elusive figure named Hai Bin Zhou.1 At least one of Hai Bin

Zhou’s business strategies involves using otherwise passive entities to register trademarks

associated with established businesses, with the expectation that companies will settle to

secure their marks.

Hai Bin Zhou pursued this strategy against Anbang. Anbang fought back until 2018,

when the insurance regulator in the People’s Republic of China took over Anbang’s

operations and placed the company in receivership. The regulatory team decided to stop

asserting Anbang’s rights to its trademarks in the United States. As a result, Anbang

defaulted in litigation with Hai Bin Zhou before the United States Patent and Trademark

Office (the “USPTO”). For Hai Bin Zhou, the default judgment was a near-term tactical

victory but a long-term strategic defeat, because it undermined his ability to extract

Free access — add to your briefcase to read the full text and ask questions with AI

Related

TSC Industries, Inc. v. Northway, Inc.
426 U.S. 438 (Supreme Court, 1976)
Lorillard Tobacco Co. v. American Legacy Foundation
903 A.2d 728 (Supreme Court of Delaware, 2006)
NACCO INDUSTRIES, INC. v. Applica Inc.
997 A.2d 1 (Court of Chancery of Delaware, 2009)
Roca v. EI Du Pont De Nemours and Co.
842 A.2d 1238 (Supreme Court of Delaware, 2004)
In Re General Motors (Hughes) Shareholder Litigation
897 A.2d 162 (Supreme Court of Delaware, 2006)
Wilmington Trust Company v. Culhane
129 A.2d 770 (Court of Chancery of Delaware, 1957)
Hollinger International, Inc. v. Black
844 A.2d 1022 (Court of Chancery of Delaware, 2004)
Duncan v. Theratx, Inc.
775 A.2d 1019 (Supreme Court of Delaware, 2001)
In Re IBP, Inc., Shareholders Litigation
789 A.2d 14 (Court of Chancery of Delaware, 2001)
Alliance Data Systems Corp. v. Blackstone Capital Partners v L.P.
963 A.2d 746 (Court of Chancery of Delaware, 2009)
E.I. Du Pont De Nemours & Co. v. Admiral Insurance Co.
711 A.2d 45 (Superior Court of Delaware, 1995)
Emerald Partners v. Berlin
726 A.2d 1215 (Supreme Court of Delaware, 1999)
Estate of Osborn Ex Rel. Osborn v. Kemp
991 A.2d 1153 (Supreme Court of Delaware, 2010)
Alta Berkeley VI C v. v. Omneon, Inc.
41 A.3d 381 (Supreme Court of Delaware, 2012)
Delaware Board of Nursing v. Gillespie
41 A.3d 423 (Supreme Court of Delaware, 2012)
Gilbert v. El Paso Co.
490 A.2d 1050 (Court of Chancery of Delaware, 1984)
Della Corporation v. Diamond
210 A.2d 847 (Supreme Court of Delaware, 1965)
Hexion Specialty Chemicals, Inc. v. Huntsman Corp.
965 A.2d 715 (Court of Chancery of Delaware, 2008)
BioLife Solutions, Inc. v. Endocare, Inc.
838 A.2d 268 (Court of Chancery of Delaware, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
AB Stable VIII LLC v. MAPS Hotels and Resorts One LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ab-stable-viii-llc-v-maps-hotels-and-resorts-one-llc-delch-2020.